• Explore /
  • Poster
  • / Paclitaxel protein bound (A) plus gemcitabine (G) plus cisplatin (C) and hydroxychloroquine (HCQ) neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC).

Paclitaxel protein bound (A) plus gemcitabine (G) plus cisplatin (C) and hydroxychloroquine (HCQ) neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC).

Abstract Poster

Authors

Erkut Borazanci

Erkut Hasan Borazanci

HonorHealth Research Institute, Scottsdale, AZ

Erkut Hasan Borazanci , Gayle S. Jameson , Courtney Edwards Snyder , Amar Thosani , Steven Sckolnik , Ronald Lee Korn , Syed Rahmanuddin , Dan Mocan , Shelby Pearse , Michael S. Gordon , Daniel D. Von Hoff , Aryan Modasi , Albert Amini

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04669197

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 667)

DOI

10.1200/JCO.2024.42.3_suppl.667

Abstract #

667

Poster Bd #

L16

Abstract Disclosures

Similar Posters

First Author: Erkut Hasan Borazanci

First Author: Shawn Peterson

Poster

2024 ASCO Gastrointestinal Cancers Symposium

The effect of germline DNA repair mutations on radiosensitivity in pancreatic ductal adenocarcinoma.

The effect of germline DNA repair mutations on radiosensitivity in pancreatic ductal adenocarcinoma.

First Author: John Michael Bryant

First Author: Satoshi Nara